UBS raised the firm’s price target on Nutrien (NTR) to $56 from $52 and keeps a Neutral rating on the shares. Nutrien’s Q1 missed estimates, though the firm sees a more modest shift higher in Q2, the analyst tells investors in a research note.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NTR:
- Nutrien Reports Strong Shareholder Support at 2025 Annual Meeting
- Nutrien Declares Quarterly Dividend of US$0.545 per Share
- Nutrien Ltd. Reports First Quarter 2025 Results, Maintains Positive Outlook
- Nutrien reports Q1 adjusted EPS 11c, consensus 30c
- Nutrien backs FY25 retail adjusted EBITDA view $1.65B-$1.85B